202 related articles for article (PubMed ID: 35164752)
1. O-GlcNAc transferase couples MRE11 to transcriptionally active chromatin to suppress DNA damage.
Gondane A; Girmay S; Helevä A; Pallasaho S; Loda M; Itkonen HM
J Biomed Sci; 2022 Feb; 29(1):13. PubMed ID: 35164752
[TBL] [Abstract][Full Text] [Related]
2. High OGT activity is essential for MYC-driven proliferation of prostate cancer cells.
Itkonen HM; Urbanucci A; Martin SE; Khan A; Mathelier A; Thiede B; Walker S; Mills IG
Theranostics; 2019; 9(8):2183-2197. PubMed ID: 31149037
[TBL] [Abstract][Full Text] [Related]
3. Castration-resistant prostate cancer cells are dependent on the high activity of CDK7.
Pallasaho S; Gondane A; Kuivalainen A; Girmay S; Moestue S; Loda M; Itkonen HM
J Cancer Res Clin Oncol; 2023 Jul; 149(8):5255-5263. PubMed ID: 36401094
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of O-GlcNAc Transferase Renders Prostate Cancer Cells Dependent on CDK9.
Itkonen HM; Poulose N; Steele RE; Martin SES; Levine ZG; Duveau DY; Carelli R; Singh R; Urbanucci A; Loda M; Thomas CJ; Mills IG; Walker S
Mol Cancer Res; 2020 Oct; 18(10):1512-1521. PubMed ID: 32611550
[TBL] [Abstract][Full Text] [Related]
5. O-GlcNAc transferase maintains metabolic homeostasis in response to CDK9 inhibition.
Gondane A; Poulose N; Walker S; Mills IG; Itkonen HM
Glycobiology; 2022 Aug; 32(9):751-759. PubMed ID: 35708495
[TBL] [Abstract][Full Text] [Related]
6. Identification of a diketopiperazine-based O-GlcNAc transferase inhibitor sensitizing hepatocellular carcinoma to CDK9 inhibition.
Shan X; Jiang R; Gou D; Xiang J; Zhou P; Xia J; Wang K; Huang A; Tang N; Huang L
FEBS J; 2023 Sep; 290(18):4543-4561. PubMed ID: 37247228
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of CDK9 activity compromises global splicing in prostate cancer cells.
Hu Q; Poulose N; Girmay S; Helevä A; Doultsinos D; Gondane A; Steele RE; Liu X; Loda M; Liu S; Tang DG; Mills IG; Itkonen HM
RNA Biol; 2021 Nov; 18(sup2):722-729. PubMed ID: 34592899
[TBL] [Abstract][Full Text] [Related]
8. O-GlcNAc transferase integrates metabolic pathways to regulate the stability of c-MYC in human prostate cancer cells.
Itkonen HM; Minner S; Guldvik IJ; Sandmann MJ; Tsourlakis MC; Berge V; Svindland A; Schlomm T; Mills IG
Cancer Res; 2013 Aug; 73(16):5277-87. PubMed ID: 23720054
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of O-GlcNAc transferase activity reprograms prostate cancer cell metabolism.
Itkonen HM; Gorad SS; Duveau DY; Martin SE; Barkovskaya A; Bathen TF; Moestue SA; Mills IG
Oncotarget; 2016 Mar; 7(11):12464-76. PubMed ID: 26824323
[TBL] [Abstract][Full Text] [Related]
10. Histone methyltransferase Dot1L recruits O-GlcNAc transferase to target chromatin sites to regulate histone O-GlcNAcylation.
Xu B; Zhang C; Jiang A; Zhang X; Liang F; Wang X; Li D; Liu C; Liu X; Xia J; Li Y; Wang Y; Yang Z; Chen J; Zhou Y; Chen L; Sun H
J Biol Chem; 2022 Jul; 298(7):102115. PubMed ID: 35690146
[TBL] [Abstract][Full Text] [Related]
11. Critical role of O-Linked β-N-acetylglucosamine transferase in prostate cancer invasion, angiogenesis, and metastasis.
Lynch TP; Ferrer CM; Jackson SR; Shahriari KS; Vosseller K; Reginato MJ
J Biol Chem; 2012 Mar; 287(14):11070-81. PubMed ID: 22275356
[TBL] [Abstract][Full Text] [Related]
12. O-GlcNAc Transferase - An Auxiliary Factor or a Full-blown Oncogene?
Itkonen HM; Loda M; Mills IG
Mol Cancer Res; 2021 Apr; 19(4):555-564. PubMed ID: 33472950
[TBL] [Abstract][Full Text] [Related]
13. Nutrient sensor O-GlcNAc transferase regulates breast cancer tumorigenesis through targeting of the oncogenic transcription factor FoxM1.
Caldwell SA; Jackson SR; Shahriari KS; Lynch TP; Sethi G; Walker S; Vosseller K; Reginato MJ
Oncogene; 2010 May; 29(19):2831-42. PubMed ID: 20190804
[TBL] [Abstract][Full Text] [Related]
14. O-GlcNAc Transferase Inhibition Differentially Affects Breast Cancer Subtypes.
Barkovskaya A; Seip K; Hilmarsdottir B; Maelandsmo GM; Moestue SA; Itkonen HM
Sci Rep; 2019 Apr; 9(1):5670. PubMed ID: 30952976
[TBL] [Abstract][Full Text] [Related]
15. Drosophila O-GlcNAcase Deletion Globally Perturbs Chromatin O-GlcNAcylation.
Akan I; Love DC; Harwood KR; Bond MR; Hanover JA
J Biol Chem; 2016 May; 291(19):9906-19. PubMed ID: 26957542
[TBL] [Abstract][Full Text] [Related]
16. O-GlcNAc transferase promotes glioblastoma by modulating genes responsible for cell survival, invasion, and inflammation.
Sheikh MA; Alawathugoda TT; Vyas G; Emerald BS; Ansari SA
J Biol Chem; 2023 Oct; 299(10):105235. PubMed ID: 37689115
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of O-GlcNAc by prostate cancer cells is significantly associated with poor prognosis of patients.
Kamigaito T; Okaneya T; Kawakubo M; Shimojo H; Nishizawa O; Nakayama J
Prostate Cancer Prostatic Dis; 2014 Mar; 17(1):18-22. PubMed ID: 24366413
[TBL] [Abstract][Full Text] [Related]
18. Cross-talk between two essential nutrient-sensitive enzymes: O-GlcNAc transferase (OGT) and AMP-activated protein kinase (AMPK).
Bullen JW; Balsbaugh JL; Chanda D; Shabanowitz J; Hunt DF; Neumann D; Hart GW
J Biol Chem; 2014 Apr; 289(15):10592-10606. PubMed ID: 24563466
[TBL] [Abstract][Full Text] [Related]
19. H3K4me3 remodeling induced acquired resistance through O-GlcNAc transferase.
Ravindran Menon D; Hammerlindl H; Gimenez G; Hammerlindl S; Zuegner E; Torrano J; Bordag N; Emran AA; Giam M; Denil S; Pavelka N; Tan AC; Sturm RA; Haass NK; Rancati G; Herlyn M; Magnes C; Eccles MR; Fujita M; Schaider H
Drug Resist Updat; 2023 Nov; 71():100993. PubMed ID: 37639774
[TBL] [Abstract][Full Text] [Related]
20. A Conserved Splicing Silencer Dynamically Regulates O-GlcNAc Transferase Intron Retention and O-GlcNAc Homeostasis.
Park SK; Zhou X; Pendleton KE; Hunter OV; Kohler JJ; O'Donnell KA; Conrad NK
Cell Rep; 2017 Aug; 20(5):1088-1099. PubMed ID: 28768194
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
